Brokers Offer Predictions for CRSP FY2026 Earnings
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for CRISPR Therapeutics in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst E. Schmidt forecasts that the company will earn ($6.73) per share for the year. Cantor Fitzgerald currently has a “Neutral” rating on […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for CRISPR Therapeutics in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst E. Schmidt forecasts that the company will earn ($6.73) per share for the year. Cantor Fitzgerald currently has a “Neutral” rating on […]
